| Biotechnology Industry | Healthcare Sector | Ms. Setsuko Hashimoto Ph.D. CEO | JPX Exchange | JP3423530009 ISIN |
| Japan Country | 44 Employees | - Last Dividend | - Last Split | - IPO Date |
CellSeed Inc. operates in the forefront of regenerative medicine, focusing on developing innovative cell sheet technologies for various medical applications. Since its inception in 2001, the company has dedicated its efforts to the research, development, and commercialization of groundbreaking cell-sheet regenerative medicine products. These products are aimed at addressing a range of health issues, including esophageal regeneration, knee osteoarthritis, and more. Headquartered in Tokyo, Japan, CellSeed Inc. is at the heart of pioneering health solutions, leveraging cutting-edge science to improve patient outcomes and quality of life.
This product represents a significant advance in treating esophageal diseases by regenerating damaged esophageal tissues using cell sheet technology. It aims to restore normal function and alleviate symptoms for patients suffering from esophageal conditions.
Offering a novel approach to cartilage repair, this regenerated cartilage sheet promotes the healing of damaged cartilage, particularly benefiting individuals with joint issues such as osteoarthritis, by using engineered sheets of chondrocytes to regenerate the affected areas.
Specifically designed for the treatment of knee osteoarthritis, this chondrocyte sheet technology focuses on alleviating pain and improving mobility in patients by repairing the damaged knee cartilage.
A temperature-responsive cell cultureware that facilitates the engineering of cell sheets. UpCell represents a pivotal tool in regenerative medicine research, enabling the easy handling and transfer of delicate cell sheets without damage.
Another temperature-responsive cell cultureware, RepCell is designed for the efficient collection of cells. This innovation simplifies the process of harvesting cells for further experimentation or therapeutic application.
HydroCell offers a low cell binding cultureware solution, optimizing the conditions for cell growth and maintenance. It is particularly useful in applications where minimal interaction between the cultureware surface and the cells is desired.
CellSeed Inc. also extends its expertise through contract development and manufacturing services, offering customizable solutions to meet the specific regenerative medicine needs of its clients. This aspect of the business enables the company to collaborate with partners worldwide, fostering innovation and advancing the field of regenerative medicine.